l-carnitine fatty liver Frontiers l carnitine role transporting fatty

Researchers concluded that a subgroup of [Alzheimers] patients aged 65 or younger may benefit from treatment with [ALCAR] whereas older individuals might do more poorly. 13 A follow up study reanalyzed the results and came to similar conclusions, suggesting that ALCAR slows the progression of Alzheimers disease in younger subjects. 14 In another follow-up study that compared ALCARs effect on those with early-onset (age 45-65) and regular Alzheimers, researchers reached a different conclusion, reporting that there were no significant differences between the treatment groups. 15 ALCAR 1,500 mg seems to help with depression in the elderly In this study, 28 elderly patients aged 70-80 who had been diagnosed with depression were given either 1,500 mg Acetyl-L-Carnitine or placebo daily, and were then evaluated with three cognitive tests and by clinical observation

Neuromuscular disease Myopathy can be seen with biochemically defined defects in mitochondrial substrate transport or utilization, including the myopathic form of carnitine deficiency

LACARNIT INJECTION 5ML is used to treat primary and secondary carnitine deficiencies in patients with end-stage kidney disease who are undergoing dialysis

Nutrients , 12 (11), 3418